Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bi-Institutional Pilot Study to Evaluate the Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With WHO Grade II Low-Grade Gliomas

NCT00795457 is registered in ClinicalTrials.gov with Ian F. Pollack, M.D. as lead sponsor.

NCT NCT00795457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00795457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bi-Institutional Pilot Study to Evaluate the Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With WHO Grade II Low-Grade Gliomas
Lead sponsor
Ian F. Pollack, M.D.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2015
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, glioma, oligo-astrocytoma